175 related articles for article (PubMed ID: 15862127)
41. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
42. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
43. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
44. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
[TBL] [Abstract][Full Text] [Related]
45. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
Shi HR; Wu QH; Suo ZH; Nesland JM
Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
[TBL] [Abstract][Full Text] [Related]
46. Chemoradiation therapy induces
Sood S; Patel FD; Srinivasan R; Dhaliwal LK
Indian J Med Res; 2018 Feb; 147(2):151-157. PubMed ID: 29806603
[TBL] [Abstract][Full Text] [Related]
47. DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.
Cheng HY; Gao Y; Lou G
Eur J Med Res; 2010 Jan; 15(1):20-4. PubMed ID: 20159667
[TBL] [Abstract][Full Text] [Related]
48. Hydralazine target: from blood vessels to the epigenome.
Arce C; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Candelaria M; Dueñnas-Gonzalez A
J Transl Med; 2006 Feb; 4():10. PubMed ID: 16507100
[TBL] [Abstract][Full Text] [Related]
49. Colorectal cancer DNA methylation patterns from patients in Manaus, Brazil.
Almeida FG; de Aquino PF; de Souza AD; de Souza AQ; do Carmo Vinhote S; Mac-Cormick TM; da Mota Silva MS; Chalub SR; de Saldanha da Gama Fischer J; Carvalho PC; da Gloria da Costa Carvalho M
Biol Res; 2015 Sep; 48(1):50. PubMed ID: 26363785
[TBL] [Abstract][Full Text] [Related]
50. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs.
Lu Q; Wu A; Richardson BC
J Immunol; 2005 May; 174(10):6212-9. PubMed ID: 15879118
[TBL] [Abstract][Full Text] [Related]
51. Detection of DNA methylation. Potential applications to diagnostic cytopathology.
Pu RT; Clark DP
Acta Cytol; 2003; 47(2):247-52. PubMed ID: 12685196
[TBL] [Abstract][Full Text] [Related]
52. Anti-neoplastic properties of hydralazine in prostate cancer.
Graça I; Sousa EJ; Costa-Pinheiro P; Vieira FQ; Torres-Ferreira J; Martins MG; Henrique R; Jerónimo C
Oncotarget; 2014 Aug; 5(15):5950-64. PubMed ID: 24797896
[TBL] [Abstract][Full Text] [Related]
53. Methylation and p16: suppressing the suppressor.
Little M; Wainwright B
Nat Med; 1995 Jul; 1(7):633-4. PubMed ID: 7585141
[No Abstract] [Full Text] [Related]
54. Clinical and biological effects of demethylating agents on solid tumours - A systematic review.
Linnekamp JF; Butter R; Spijker R; Medema JP; van Laarhoven HWM
Cancer Treat Rev; 2017 Mar; 54():10-23. PubMed ID: 28189913
[TBL] [Abstract][Full Text] [Related]
55. Enhanced immunological detection of epigenetic modifications of DNA in healthy and cancerous cells by fluorescence microscopy.
Çelik-Uzuner S
Microsc Res Tech; 2019 Nov; 82(11):1962-1972. PubMed ID: 31429164
[TBL] [Abstract][Full Text] [Related]
56. A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.
Bauman J; Shaheen M; Verschraegen CF; Belinsky SA; Houman Fekrazad M; Lee FC; Rabinowitz I; Ravindranathan M; Jones DV
Transl Oncol; 2014 Apr; 7(3):349-54. PubMed ID: 24746712
[TBL] [Abstract][Full Text] [Related]
57. [Erratum to: “A comparative analysis of methylation status of tumor suppressor genes in paired biopsy and serum samples from cervical cancer patients among North Indian population”].
Jhaa AK; Sharma V; Nikbakht M; Jain V; Sehgal A; Capalash N; Kaur J
Genetika; 2016 Aug; 52(8):996. PubMed ID: 29369554
[No Abstract] [Full Text] [Related]
58. Cost-Effectiveness Analysis of Hydralazine and Magnesium Valproate LP Associated With Treatment for Adult Patients with Metastatic Recurrent or Persistent Cervical Cancer in Mexico.
Soto H; Sanchez K; Escobar JY; Constanzo A; Fernandez Z; Melendez C
Value Health; 2014 Nov; 17(7):A639. PubMed ID: 27202285
[No Abstract] [Full Text] [Related]
59. Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches.
Lanka G; Banerjee S; Adhikari N; Ghosh B
Mol Divers; 2024 Apr; ():. PubMed ID: 38637479
[TBL] [Abstract][Full Text] [Related]
60. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting.
Reshkin SJ; Cardone RA; Koltai T
Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
